Ex-Vivo Lung Perfusion – A Solution to the Lung Availability Crisis
Ex-Vivo Lung Perfusion (EVLP) is a medical procedure that could potentially reduce lung transplant surgery wait times by modifying a donor’s lungs to improve the post-operation outcomes and overall survival rate.
Many people are unaware that allocating donor organs remains to be a prominent limitation in performing transplant surgeries. The waiting list for recipients awaiting an organ has been increasing and often recipients are admitted into the hospital on life support while they wait. Ex-Vivo Lung Perfusion (EVLP) is a medical procedure that could potentially reduce wait times by modifying a donor’s lungs to improve the post-operation outcomes and overall survival rate. Dr. Steve Singh, a renowned cardiac surgeon joins the discussion to provide insight on EVLP.
[Please complete our feedback form]
Related News
News Listing
Canadian military members advance training with McMaster’s Physician Assistant program
Collaborations & Partnerships, Education, Feature
6 days ago
McMaster postdoc receives prestigious European fellowship
Dept. Biochem, Education, Michael G. DeGroote Institute for Infectious Disease Research, Research
November 6, 2024
McMaster recognized as a leader in nursing, medical and health education
Education, School of Nursing
November 5, 2024